 |
Hyderabad, April' 2002: Mr Satish Reddy,the MD & Chief
Operating Officer of Dr Reddy's Laboratories Limited has recently
been elected as the Chairman of the Andhra Pradesh Chapter of
Confederation of Indian Industry for the year 2003-2004.He takes
over from B.V.R.Mohan Reddy,Chairman and Managing Director,InfoTech
Enterprises Ltd.In 1993, he assumed the post of Executive Director in charge of the
manufacturing operations of active pharmaceutical ingredients and
formulations, research and development activities and new product
development. |
He was also Director of Cheminor, and is a member of the Indian
Institute of Chemical Engineers. Mr Reddy has a Master of Science degree
in Medicinal Chemistry from Purdue University and a Bachelor of
Technology degree in Chemical Engineering from Osmania University. Other
than subsidiaries of the Company, he is member of the Executive
Committee of FICCI.
Dr Reddy's Laboratories Limited
Dr Reddy's Laboratories is an emerging global pharmaceutical company
focused on creating and delivering innovative healthcare solutions that
enable people to lead healthier lives.
Since its inception in 1984, Dr Reddy's has chosen to walk the path of
discovery and innovation in health sciences. In a short span, the
comapany has filed for 64 patents. Dr Reddy's are the first Indian
Company to out-license a molecule for clinical trials to Novo Nordisk
the world leader in diabetes. To strengthen its research arm, the
company has set up a research subsidiary, Reddy US Therapeutics Inc., in
Atlanta, USA.
Dr Reddy's export bulk actives, branded formulations and generic
formulations to over 60 countries. A few of its bulk drugs such as
Norfloxacin, Ciprofloxacin and Enrofloxacin enjoy a large customer
base.Its finished dosages have an enviable track record. Some of them
such as Nise, Omez, Enam, Stamlo, Stamlo Beta and Ciprolet are among the
top brands in India, and many have become household names in developing
countries too. Dr Reddy's generic formulations have also become very
popular in quality-conscious regulated markets such as the US, Europe
and Japan.
MK
Reachout's News Bureau
-April' 2003 |
